Anika Therapeutics, Inc. — Investor Relations & Filings
Filings indexed
1,017
across all filing types
Latest filing
2026-02-03
Director's Dealing
Country
US
United States of America
Listing
US
ANIK
Anika Therapeutics, Inc. is a global joint preservation company focused on developing, manufacturing, and marketing solutions for early intervention orthopedic care. The company provides a range of therapeutic products and regenerative solutions designed to treat degenerative orthopedic diseases, traumatic conditions, joint pain, and arthritis. Its portfolio, which utilizes technologies such as hyaluronic acid, aims to restore joint function and enable patients to maintain an active lifestyle. Key products include the Integrity™ Implant System, a regenerative scaffold for tendon augmentation. Anika partners with medical professionals to deliver treatments across the continuum of joint care.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 4 Filing | 2026-02-03 | English | |
| SCHEDULE 13D/A Filing | 2026-01-27 | English | |
| 8-K Filing | 2026-01-08 | English | |
| SCHEDULE 13G/A Filing | 2026-01-08 | English | |
| Major Shareholding Notification 2025 | 2025-11-21 | English | |
| Major Shareholding Notification 2025 | 2025-11-07 | English |
Browse filings by year
26 years- 2026 19 filings
- 2025 45 filings
- 2024 54 filings
- 2023 55 filings
- 2022 50 filings
- 2021 48 filings
- 2020 60 filings
- 2019 47 filings
- 2018 46 filings
- 2017 53 filings
- 2016 43 filings
- 2015 39 filings
- 2014 38 filings
- 2013 47 filings
- 2012 34 filings
- 2011 37 filings
- 2010 29 filings
- 2009 31 filings
- 2008 40 filings
- 2007 26 filings
- 2006 51 filings
- 2005 38 filings
- 2004 41 filings
- 2003 30 filings
- 2002 11 filings
- 2001 5 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
4 filings
| |||||
| 25442048 | 4 Filing | 2026-02-03 | English | ||
| 25441893 | SCHEDULE 13D/A Filing | 2026-01-27 | English | ||
| 25442013 | 8-K Filing | 2026-01-08 | English | ||
| 25441967 | SCHEDULE 13G/A Filing | 2026-01-08 | English | ||
|
2025
11 filings
| |||||
| 10005449 | Major Shareholding Notification 2025 | 2025-11-21 | English | ||
| 10005450 | Major Shareholding Notification 2025 | 2025-11-07 | English | ||
| 10005451 | FORM S-8 | 2025-11-05 | English | ||
| 10005452 | FORM 10-Q | 2025-11-05 | English | ||
| 10005453 | FORM 8-K | 2025-11-05 | English | ||
| 10005454 | Major Shareholding Notification 2025 | 2025-10-17 | English | ||
| 10005455 | FORM 10-Q | 2025-07-30 | English | ||
| 10005456 | FORM 8-K | 2025-07-30 | English | ||
| 10005457 | FORM 8-K | 2025-07-30 | English | ||
| 10005458 | Regulatory Filings 2025 | 2025-07-24 | English | ||
| 10005459 | Regulatory Filings 2025 | 2025-07-17 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Anika Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33997/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33997 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33997 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33997 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33997}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Anika Therapeutics, Inc. (id: 33997)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.